Alterations in EGFR and PDGFRA are associated with the localization of contrast-enhancing lesions in glioblastoma.
Ryutaro MakinoNayuta HigaToshiaki AkahaneHajime YonezawaHiroyuki UchidaTomoko TakajoShingo FujioMari KirishimaTaiji HamadaHitoshi YamahataKiyohisa KamimuraTakashi YoshiuraKoji YoshimotoAkihide TanimotoRyosuke HanayaPublished in: Neuro-oncology advances (2023)
alteration correlated with multiple lesions. Our results suggest that clarifying the association between driver genes and tumor localization may be useful in clinical practice, including prognosis prediction.